These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 18501234

  • 1. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
    Nichols GA, Hillier TA, Brown JB.
    Am J Med; 2008 Jun; 121(6):519-24. PubMed ID: 18501234
    [Abstract] [Full Text] [Related]

  • 2. Normal fasting plasma glucose levels and type 2 diabetes in young men.
    Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A, Israeli Diabetes Research Group.
    N Engl J Med; 2005 Oct 06; 353(14):1454-62. PubMed ID: 16207847
    [Abstract] [Full Text] [Related]

  • 3. The incidence of heart failure among nondiabetic patients with and without impaired fasting glucose.
    Nichols GA, Koro CE, Kolatkar NS.
    J Diabetes Complications; 2009 Oct 06; 23(3):224-8. PubMed ID: 18413158
    [Abstract] [Full Text] [Related]

  • 4. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
    Ryu S, Chang YS, Kim DI, Suh BS, Kim WS.
    J Prev Med Public Health; 2005 May 06; 38(2):203-7. PubMed ID: 16315759
    [Abstract] [Full Text] [Related]

  • 5. Levels of plasma fibrinogen and d-dimer in patients with impaired fasting glucose.
    Coban E, Sari R, Ozdogan M, Akcit F.
    Exp Clin Endocrinol Diabetes; 2005 Jan 06; 113(1):35-7. PubMed ID: 15662593
    [Abstract] [Full Text] [Related]

  • 6. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE.
    Circulation; 2007 Jul 10; 116(2):151-7. PubMed ID: 17576864
    [Abstract] [Full Text] [Related]

  • 7. Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population.
    Nagaya T, Yoshida H, Takahashi H, Kawai M.
    Diabet Med; 2005 Aug 10; 22(8):1107-11. PubMed ID: 16026381
    [Abstract] [Full Text] [Related]

  • 8. The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men.
    Park YW, Chang Y, Sung KC, Ryu S, Sung E, Kim WS.
    Diabetes Res Clin Pract; 2006 Sep 10; 73(3):329-35. PubMed ID: 16600415
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.
    Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER.
    Arch Intern Med; 2005 Oct 24; 165(19):2299-304. PubMed ID: 16246998
    [Abstract] [Full Text] [Related]

  • 12. Alcohol consumption and higher incidence of impaired fasting glucose or type 2 diabetes in obese Korean men.
    Roh WG, Shin HC, Choi JH, Lee YJ, Kim K.
    Alcohol; 2009 Dec 24; 43(8):643-8. PubMed ID: 20004342
    [Abstract] [Full Text] [Related]

  • 13. Factors related to the development of diabetes during a 20-year follow-up. A prospective study in a homogeneous group of middle-aged men.
    Strandberg TE, Salomaa V.
    Nutr Metab Cardiovasc Dis; 2000 Oct 24; 10(5):239-46. PubMed ID: 11213532
    [Abstract] [Full Text] [Related]

  • 14. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT, Cockram CS, Chan JC.
    J Med; 2001 Oct 24; 32(1-2):53-65. PubMed ID: 11321888
    [Abstract] [Full Text] [Related]

  • 15. The relationship between resting heart rate and atherosclerosis risk factors.
    Piwońska A, Piotrowski W, Broda G, Drygas W, Głuszek J, Zdrojewski T, Kozakiewicz K, Stepaniak U, Bandosz P.
    Kardiol Pol; 2008 Oct 24; 66(10):1069-75; discussion 1076-8. PubMed ID: 19006028
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
    Tenenbaum A, Motro M, Fisman EZ, Schwammenthal E, Adler Y, Goldenberg I, Leor J, Boyko V, Mandelzweig L, Behar S.
    Circulation; 2004 May 11; 109(18):2197-202. PubMed ID: 15123532
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
    Valdés S, Botas P, Delgado E, Alvarez F, Cadórniga FD.
    Diabetes Care; 2007 Sep 11; 30(9):2258-63. PubMed ID: 17536076
    [Abstract] [Full Text] [Related]

  • 20. Type 2 diabetes and impaired fasting blood glucose in rural Bangladesh: a population-based study.
    Hussain A, Vaaler S, Sayeed MA, Mahtab H, Ali SM, Khan AK.
    Eur J Public Health; 2007 Jun 11; 17(3):291-6. PubMed ID: 17008328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.